Sulfonamide type of drug. Clinical experience points to non-porphyrinogenicity. There are references that warn against the drug. Combined with potassium chloride.

Thiazide diuretic and antihypertensive.

The major part of the drug is eliminated via non-renal mechanisms, only 30 % excreted in unchanged form in urine. More specific data on metabolism are lacking. No observations of CYP interaction. Bendroflumethiazide is a sulfonamide type drug, a drug group often incriminated in acute porphyric attacks. Combined with potassium chloride.

Thunell, patient report (n=1): tolerated. Andersson, patient report (n=11): tolerated.

None.

Uneventful use reported in 1 patient with acute porphyria.